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CASE REPORT
Disseminated Nocardiosis in renal 
transplant recipient under therapy 
for pulmonary tuberculosis: a case report
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Abstract 
Background: Nocardiosis is an opportunistic infection in a patient with underlying immune suppression and organ 
transplant. Clinical syndromes are varied and ranges from pulmonary, disseminated, cutaneous along with central 
nervous system involvement.
Case presentation: Herein, we report a rare case of disseminated pulmonary nocardiosis with cerebral manifestation 
in a 66 year-old-Nepali farmer; with a history of renal transplantation and undergoing therapy for pulmonary tuber-
culosis. Radiographic imaging revealed multiple opacities of varying sizes in bilateral lung field mediastinal, retroperi-
toneal lymphadenopathy, and ill-defined lesion with surrounding edema seen in left occipitoparietal region of brain. 
Bacteriological assessments of bronchoalveolar lavage and purulent fluid extracted intra-operatively from the lesion 
confirmed the case as Nocardiosis.
Conclusion: Disseminated Pulmonary nocardiosis with central nervous system involvement carries a poor progno-
sis. However, early diagnosis of the case, the administration of appropriate antibiotic, stereotactic aspiration alone or 
craniotomy has a successful outcomes even in a post renal transplant patient treated with anti tuberculosis treatment.
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Background
Nocardiosis, is an opportunistic infection particularly 
in a patient with underlying immune suppression. The 
clinical syndromes varies and range from pulmonary, dis-
seminated, cutaneous form involving eyes, kidneys, skin, 
bone and CNS. The clinical manifestations may be subtle 
with the radiological findings mimicking other entities 
such as malignancy. The organism requires multiple days 
to grow in culture, thus detection and early treatment 
may be delayed [1]. The lungs are presumed as primary 
site of infection (60–80% of cases) and brain abscess is, 
by far, the most common complication conferring poor 
prognosis [2, 3]. Although, Nocardial cerebral abscesses 
account for only 1 to 2% of all cerebral abscesses the mor-
tality rate due to it is considerably higher accounting for, 
55 and 20% in immunocompromised and immunocom-
petent patients, respectively [4]. Treatment is based on 
stereotaxic aspiration or surgical resection, and a course 
of antibiotics therapy for several months. Since, It has 
been estimated that the prevalence of Nocardiosis and 
concomitant infection with tuberculosis is more than 
6.25%, early detection can be a lifesaving approaches [5].
We present a case of disseminated nocardiosis in renal 
transplant recipient who presented with pulmonary and 
cerebral manifestation. The stereotaxic aspiration or sur-
gical resection, and antibiotics therapy (trimethoprim/
sulfamethoxazole) for several months was found to be 
crucial for prognosis.
Case presentation
A 66-year-old Nepali farmer from Kathmandu with a his-
tory of renal transplant in July 2013 undergoing medi-
cation for pulmonary tuberculosis since 4th June, 2014.
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The person was habitual of smoking, chewing tobacco 
and cannabis, with hypertensive past history. After 
4  month of ATT the patient acquired perinephric hae-
motoma which was drained out twice with pig tail drain-
age. Nearly, after 2  month (January 2015) the patient 
was admitted in TUTH under Nephrology unit with a 
chief complain of altered sensorium, hyponatremia and 
twitching of face. Following the admission, pyrazinamide 
was stopped from ATT until symptomatic improvement 
of the clinical case and re-added after a month following 
the Gene Xpert report. Tacrolimus level was assessed as 
6.5 micro gm/dl with normal PBS, RFTs, and LFTs and 
the patient was discharged after 9 days. Six months later 
on June 1st, 2015, the patient was readmitted after the 
clinical findings of right UMN Facial palsy and slight pro-
nator drift. A chief complain of chest pain, coughing and 
evening rise of fever was revealed by the patient prior to 
hospital re-admission. The physical examination revealed 
no limbs swelling, palpitations and loss of consciousness. 
No lymphadenopathy and organomegally was noted.
Contrast Enhanced Computed tomography of chest 
and abdomen showed multiple opacities of varying sizes 
in bilateral lung field mediastiral and retroperitoneal 
lymphadenopathy. Hyperdense area with enhancing wall 
in subcutaneous plane and muscular plane in abdomen 
and pelvis was observed.
Computed tomography scan of brain revealed an ill-
defined lesion with surrounding edema in left occipito-
parietal region, low grade glioma, granulomatous lesion, 
possibly tuberculoma (Figs. 1, 2). Differential diagnosis of 
abscess and contrast was suggested.
Presumptive identification was done with labora-
tory examination involving staining of broncho- alveo-
lar lavage and purulent fluid from the lesion which was 
extracted intra-operatively. The laboratory findings 
revealed gram variable, acid fast branching rod sugges-
tive Nocardia species (Fig. 3). Furthermore, upon aerobic 
culture of broncho-aleveolar lavage and purulent fluid 
from the lesion, chalky white adherent colonies were 
seen after 72  h of incubation with molar tooth appear-
ance on Blood agar, Chocolate agar, LJ media and areal 
hyphae was observed on tap water agar (Figs. 4, 5, 6, 7) as 
identified through biochemical tests and results of antibi-
otic susceptibility tested carried out in compliance with 
the Manual of Clinical Microbiology and guidelines [6]. 
However, culture was negative for the fungal elements 
and blood culture was sterile. CSF examination includ-
ing culture and assay for malignant cell was found to be 
negative.
Fig. 1 Head Computed tomography scan: ill-defined lesion with sur-
rounding edema seen in left occipitoparietal region
Fig. 2 Head Computed tomography scan: ill-defined lesion with sur-
rounding edema seen in left occipitoparietal region
Fig. 3 AFB staining: partially acid fast branching rod suggestive 
Nocardia species on modified. Kinyounstain (1000×  orginalmagnifica-
tion)
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Laboratory investigations of blood demonstrated neu-
trophil leukocytosis (1250), reduced hemoglobin (10  g/
dl), C-reactive protein (positive), Rubella and CMV (Neg-
ative: ELISA), CMV retinitis (negative), Cryptococcal 
antigen(negative), Toxosecretory IgM (positive: ELISA). 
However the serological test for, Toxoplasma-specific 
IgM was later considered to be not infected. The patient’s 
blood was redrawn two weeks after the first and second 
tested together with the first specimen. Latter test revealed 
the patient to be negative for Toxoplasma-specific IgG 
and positive for toxoplasma-specific IgM confirming the 
earlier result of positive ELISA for Toxosecretory IgM to 
be false positive [8]. RFTs (urea, creatinine, electrolytes) 
ranges were normal and Tumor markers within normal 
limits (PSA, CEA,CA19.9).Urinary albumin(1+) was seen 
on routine urine examination. In view of examination 
and investigations, a diagnosis of disseminated pulmo-
nary nocardiosis with CNS manifestations was made on 
post renal transplant patient under therapy for pulmonary 
tuberculosis. Stereotactic aspiration and craniotomy was 
performed for clinical management of the case and was 
treated with BACTRIM-DS (PO × BD), 2 double strength 
tablets each containing 800  mg sulfamethoxazole and 
160 mg trimethoprim were prescribed. The patient recov-
ered well after operation without neurological deficits, 
and then was discharged with prescription of 3  months 
antibiotic therapy to follow. The same medication was con-
tinued for 12  months as the patient underwent progres-
sive changes and no relapse was noted with his transplant 
function observed in a good state. Given the progressive 
recovery of the patient without any symptoms that would 
alert the presence of disorder additional or alternative par-
enteral antimicrobial therapies of carbapenems (imipe-
nem or meropenem, but not ertapenem), third generation 
cephalosporins (cefotaxime or ceftriaxone), and amika-
cin, alone or in combination were thought unnecessary to 
include in regimen though recommended by some author. 
Duration of antimicrobial therapy was further extended to 
minimize risk of late relapse. He is under regular follow-up 
since then and we found him asymptomatic, with limited 
side effects of prolonged antimicrobial therapy. Figure  8 
graphically shows a time line of clinical history of patient 
and diagnostic approaches.
Discussion
Post-transplantation TB is predominantly the result of 
reactivation of an earlier quiescent TB focus, previous TB 
anamnesis and family history, nosocomial acquisition or 
Fig. 4 Colonial morphology of Nocardia species on Blood 
Agar:Whitish chalky adherent colonies of Nocardia species
Fig. 5 Colonial morphology of Nocardia species on Chocolate 
Agar:Whitesh chalky adherent colonies of Nocardia species
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donor transmission, extended time spent on dialysis, pro-
longed pre-transplant hemodialysis, previous history of 
TB (9.5 to 13.5  %), Immunosuppressive drugs (steroids, 
mycophenolate mofetil, azathioprine, tacrolimus, anti-
lymphocyte serum), diabetes and multiple episodes of 
acute rejection [7]. The incidence of post transplantation 
tuberculosis observed in developing countries is about 20 
to 74 folds higher than that to the general population.
Apart from these, Anti-tuberculosis drugs have their 
own spectrum of hematological toxicity and blood cell 
abnormalities along with drugs induced syndromes 
(hemolytic anemia, methemoglobinemia, red cell apla-
sia, sideroblastic anemia, megaloblastic anemia, poly-
cythemia and aplastic anemia) [8]. On the same basis, it 
raise concerns that the use of various antibacterial agents 
affect natural immune functions essential to the clear-
ance of invading microorganisms, particularly in patients 
known to be at higher risk of acquiring secondary 
infections [9]. Nocardiosis is prior of such secondary 
infection in above presented circumstances.
Nocardia is classically described as gram-variable, aer-
obic, filamentous, branching, weakly acid-fast bacilli; in 
various sub-optimal growth conditions. Nocardia may 
appear gram-negative and acid-fast-stain negative with 
longer incubations period for growth. Hence, Identifica-
tion of Nocardia species in the clinical laboratory is chal-
lenging and high index of suspicion should be maintained 
where the patient symptomatology and chronicity of the 
diseases suggests or point towards an alternative diagno-
sis of nocardiosis.
Pulmonary nocardiosis with CNS manifestations is by 
far the most common in patients with post-transplant 
immunosuppression and immune suppressive drugs (tac-
rolimus, mycophenolatemofetil, and prednisolone) as 
discussed in the case under current consideration.
Nocardiosis tends to behave as pyogenic bacteria, pos-
sibly metastasizes haematogenously into distant organs 
system (lungs, central nervous system, eyes, kidneys, 
skin, subcutaneous tissue and bone) resulting fatal out-
comes. Pulmonary involvement is the most common 
nocardial infection characterized with alveolar or inter-
stitial infiltrates, single or multiple nodules, along with or 
without cavitation [10]. Pulmonary nocardiosis is a well 
described infection with neoplastic disease, HIV infec-
tion, and those receiving treatments with corticosteroids 
or various chemotherapeutic agents.
Virulent Nocardia species inhibits neutrophilic killing 
by macrophage via high levels of enzymes catalase and 
superoxide dismutase, and can pass the through endothe-
lial cells to invade the brain where it infects both micro-
glia and astrocytes. The Nocardia species have a special 
tropism for the neural tissue and most common site for 
Fig. 6 Colonial morphology of Nocardia species on Lowenstein–
Jensen media:Whitesh chalky adherent colonies of Nocardia species
Fig. 7 Colonial morphology of Nocardia species on Tapwater agar:Tap 
water agar showing areal hyphae
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Diagnosed as CKD
Renal transplant from Brother
Diagnosed case of pulmonary tuberculosis symptoms 
free aer 4 month of therapy
• Altered sensorium stopped pyrazinamide for a month 
• Gene Xpert sensive to Rif
• ATT connue 
• Tacrolimus drug test 6 micro gm/L
Pernephric collecon two episode of pig tail drainage 
Facial twitching and paent stops speaking clonaz added 
paent start speaking slowely symptomacally treatment
• Admied with facial palsy
• Ill differenated lesion with edema seen in le 
occipitoparietal region on CT scan of brain
• Haemoroides 
• Chest pain coughing and conspaon
• CECT and CT(mulple opacies of varying sizes in 
bilateral lung field mediasral and retroperitoneal 
lymphadenopathy)
• Ill differenated lesion with edema seen in le 
occipitoparietal region ,low grade glioma 
,granulomatous lesion, tuberculoma
• BAL and Plurulunt fluid from lesion extracted 
intraoperavely confirmed the case as Nocardiosis
• Toxosecretory IgM posive
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2015  6th May
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2015    9th June
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Fig. 8 Timeline
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their dissemination is the brain. CNS Nocardiosis may 
progress or relapse despite the physician’s best efforts to 
control the infection through antimicrobial therapy, with 
cure rates in brain abscesses reported at 50% and mortal-
ity as high as 55% [1]. The Nocardial brain abscesses is 
extremely rare, to the best of our knowledge, it is the first 
case reported from Nepal.
Clinical symptoms and Radiological Imaging findings 
are non-specific for diagnosis of Nocardiosis, however 
it’s importance cannot outweighed for the differential 
diagnosis. The presumptive identification of our case 
was done via staining of broncho-alveolar lavage and 
purulent fluid from the lesion intra-operatively; which 
revealed gram variable, acid fast branching rod sugges-
tive Nocardia species. Furthermore, on aerobic culture 
chalky white adherent colonies seen after 72  h of incu-
bation which turns molar tooth appearance on further 
incubation. Later on the organism was isolated as Nocar-
dia asteroides with biochemical interpretation and sensi-
tivity pattern of antibiotics following the CLSI guidelines.
The treatment of choice recommended by multiple 
authors, for disseminated pulmonary nocardiosis with 
CNS manifestation is long term sulfonamide therapy 
alone or in combination with imipenem, meropenem, 
amikacin, ampicillin, 3rd generation cephalosporins, 
fluoroquinolones or minocycline [10]. Studies have dem-
onstrated more than adequate penetration of antimicro-
bials into brain abscesses but differences in outcomes 
have based on surgical treatment, whether patients 
received stereotactic aspiration alone or craniotomy [1].
Nevertheless, the possibility of late recurrent nocardi-
osis could be pitfall to the successful outcomes. Hence-
forth, clinical management along with the consistent 
follow up is decisive. The recurrence of CNS nocardio-
sis is a multifactorial which depends on immune status 
of the patient, duration of antimicrobial prophylaxis after 
primary infection, the antimicrobial susceptibility pro-
file of nocardial strains, and, potentially, the poor pen-
etration of drugs to the CNS and so on [11]. It has been 
projected that the patient receiving TMP-SMX confer a 
relapse rate of about 13.6% (compared to 32% mortality 
rate and 16% relapse rate in patients who did not receive 
TMP-SMX) [11]. These are the facts that imperil for the 
consideration of clinical management in nocardiosis.
The burden and case related to disseminate nocardio-
sis in developing countries like Nepal is undetermined 
but speculated to be sporadic. The unfamiliarity with 
the case, nonspecific or lack of pathognomonic clinical 
presentation, diagnostic intricacies, and lack of system-
atic reporting preclude further work up for nocardiosis. 
Therefore, multidisciplinary approach, utilizing specia-
tion and sensitivity testing as well as appropriate surgical 
treatment, is critical to early microbial control of cerebral 
nocardiosis [12, 13]. Furthermore, appropriate diagnos-
tic strategies are needed because clinical manifestations 
may be subtle and the appearance on imaging may mimic 
other entities such as malignancy and hence would be a 
tool to preventing relapse cases.
Conclusion
Since the clinical and radiological manifestations are 
nonspecific and micribiological diagnosis is often difficult 
(Fig.  8). Nocardiosis should be considered in differen-
tial diagnosis among immunocompromised individuals, 
and recognition of predisposing factors is decisive for 
the prognosis. Apart from these a high index of clinical 
suspicion together with close collaboration with micro-
biological laboratory allows for more accurate diagnosis 
to initiate appropriate therapy, hence to reduce mortality 
significantly.
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